Remember: Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
Study Details
Study Description
Brief Summary
This study is to compare the safety and effects of donepezil (Aricept) for patients reporting cognitive or memory issues after receiving chemotherapy for breast cancer. Patients will receive either donepezil or placebo for 24 weeks. The primary objective is to see if memory improves with the use of donepezil during the study.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Detailed Description
Randomized, double-blind, placebo-controlled study with 24 weeks of exposure to drug or placebo followed by a 12 week wash-out period. Patients who meet the eligibility criteria will be stratified by age (<50, 50-59, 60-69, ≥70) and randomized to donepezil or placebo with equal probability. A total of 276 patients will be enrolled (138 per arm). We expect an accrual rate of 7-10 participants per month based on our prior feasibility study. We expect the study to be complete within 40 months.
Participants will be asked to take one 5mg tablet of donepezil or one tablet of matching placebo orally once a day for 6 weeks followed by two 5mg tablets (10mg total) of donepezil or two placebo tablets orally once a day for 18 weeks. After 24 weeks, participants will begin a 12 week wash-out period.
Time points for performing study assessments. Participants will be administered the cognitive battery of tests and questionnaires at baseline, week 12, week 24 and week 36. In addition, a single vial of blood will be drawn at baseline for APOE genotyping and subsequent bioassays (pending supplemental funding).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Donepezil Participants will be asked to take one 5 mg tablet of donepezil daily for 6 weeks followed by two 5 mg tablets daily for 18 weeks. After 24 weeks, participants will begin a 12 week wash-out period. |
Drug: Donepezil 5 mg
Participants will be asked to take one 5 mg tablet of donepezil daily for 6 weeks followed by two 5mg tablets daily for 18 weeks. After 24 weeks, participants will begin a 12 week wash-out period.
Other Names:
|
Placebo Comparator: Placebo Participants will be asked to take one tablet of matching placebo daily for 6 weeks followed by two tablets daily for 18 weeks. After 24 weeks, participants will begin a 12 week wash-out period. |
Drug: Placebo
Participants will be asked to take one tablet of matching placebo daily for 6 weeks followed by two tablets daily for 18 weeks. After 24 weeks, participants will begin a 12 week wash-out period.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Changes in Hopkins Verbal Learning Test-Revised (HVLT-R) Results [Baseline and Week 24]
The HVLT-R measures verbal learning and memory. It consists of a 12-item word list which is read to subjects on three successive learning trials. Free recall scores are recorded for each learning trial. Scores for immediate recall (total of three trials), delayed recall (total number of words recalled after 20 minutes), and recognition (total number of words correctly identified) will be the variables derived from the HVLT-R.
Secondary Outcome Measures
- Changes in Digit Symbol Coding Results [Baseline and Week 24]
The DSC test measures processing speed. It requires respondents to transcribe symbols (e.g., >) associated with a number (0-9) into empty boxes beneath a series of randomly ordered numbers. Total score is number of correctly transcribed symbols in 2 minutes. Scores range from 0-133.
- Changes in PROMIS 7-item Fatigue Scale Results [Baseline and Week 24]
This self-report scale assesses fatigue. Scale ranges from 7 to 35, with higher scores representing more fatigue.
- Changes in FACT-Cognition (Version 3) Results [Baseline and Week 24]
This is a validated self-report questionnaire that assesses patients' perceptions of their cognitive function and the impact of cognitive problems on overall quality of life over the prior 7 days. Higher scores reflect better cognitive functioning and less impairment.
- Changes in Controlled Oral Word Association Test (COWA) Results [Baseline and Week 24]
The COWA measures speed of mental processing, verbal fluency, and executive function. Subjects are asked to name as many words as possible all beginning with a specified letter. A total of three trials are administered, each with a different letter (F-A-S). The score on the COWA is the total number of words named across the three trials minus repetitions.
- Changes in Trail Making Test, Parts A & B (TMT-A, TMT-B) Results [Baseline and Week 24]
Part A of the TMT measures attention and visual motor skills and processing speed and requires subjects to connect 25 numbered circles in the proper sequence (1-2-3-…) as quickly as possible. TMT-B is similar except subjects are required to connect dots in an alternating numerical and alphabetical sequence (1-A-2-B-…). TMT-B with its added complexity and set shifting requirements is a widely used measure of executive function. The score for TMT-A and TMT-B is the total time in seconds required to complete the task. Scores can also be generated for number of errors and number of circles correctly connected.
- Digit Span Test-Backwards (DST-B) [Baseline and Week 24]
The DST-B assesses attention and working memory. It requires respondents to repeat back in reverse order spans of numbers. Seven pairs of spans of increasing lengths are presented and repeated. A total score is the number of correctly repeated spans.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Women ≥18 years old with history of invasive breast cancer
-
Must have completed at least 4 cycles of adjuvant/neo-adjuvant cytotoxic chemotherapy between 1 and 5 years prior to registration (Ongoing herceptin or other chronic HER 2 directed therapies are allowed).
-
Patients receiving ongoing hormonal therapy for breast cancer must be on the same hormonal agent for at least 3 months prior to study registration and plan to continue for the duration of the study (9 months)
-
Use of psychotropic medications (anti-depressants, anxiolytics, sleeping aids, narcotics) is permitted (patient will be asked to list any that have been taken within the last 3 days on the recent medication sheet) if dose is stable over previous 12 weeks. Patients who were previously on one of these psychotropic medications and have subsequently discontinued the drug must have been off the medication for at least 4 weeks prior to enrollment. Patients who have been on a psychotropic medication for at least 12 weeks but have recently switched to a medicine in the same class (for example, switching from one SSRI antidepressant to a different SSRI antidepressant) need to be on a stable dose of the new medication for at least 4 weeks prior to enrollment to be eligible.
-
Self-reported cognitive problem plus a measured memory deficit (score <7 on single trial of Eligibility Pre-screen HVLT-R Form 3).
-
ECOG performance status 0-2
-
Ability to understand and the willingness to sign a written informed consent document.
-
Must be able to speak English.
-
Patients currently taking a moderate risk QTc prolongation medication (see Appendix A) are allowed if one of the following criteria are met: 1) The moderate risk QTc prolongation medication is stopped. The patient should be off the moderate risk QTc prolongation medication for at least 5 half-lives before starting study drug. 2) Patients that continue using a moderate risk QTc prolongation medication must have a normal QTc interval (≤ 460 milliseconds) on a screening ECG following informed consent and prior to study enrollment. These patients will also be monitored at designated study follow-up visits per Section 7.5 (monitored 3-7 days after initiating study drug, at week 3, and 3-7 days after the study drug dose increase with ECG's to assess the QTc interval; the QTc level must be ≤ 500 milliseconds at these time points in order to continue on the study drug). 3) Moderate risk QTc prolongation medications that are only taken occasionally may be stopped at the discretion of the treating site physician. Patients must be off medication for at least 5 half-lives prior to starting study drug to be eligible.
-
Patients currently taking a moderate risk bradycardia-causing agent (see Appendix B) are allowed if one of the following criteria are met: 1) The moderate risk bradycardia-causing agent is stopped. The patient should be off the moderate risk bradycardia-causing agent for at least 5 half-lives before starting study drug. 2) Patients that continue using a moderate risk bradycardia-causing agent must have a resting heart rate ≥ 55 beats per minute at screening following informed consent. These patients' resting heart rate will be monitored 3-7 days after initiating study drug, at week 3, and 3-7 days after the study drug dose increase per Section 7.5. 3) Moderate risk bradycardia-causing agents that are only taken occasionally may be stopped at the discretion of the treating site physician. Patients must be off medication for at least 5 half-lives prior to starting study drug to be eligible.
Exclusion Criteria:
-
Evidence or suspected recurrent or metastatic disease.
-
Prior brain irradiation is not allowed.
-
Planned therapy (surgery, radiation, chemotherapy, or immunotherapy) while on the study for brain and/or extracranial primary/metastatic disease.
-
Hypersensitivity to donepezil or piperidine derivatives
-
Current use of ceritinib
-
Current use of Succinylcholine/Acetylcholinesterase Inhibitors(as listed in Appendix C). For patients who have used these medications, they must not have used them within 4 weeks prior to enrollment.
-
Current use of high-risk QTc prolonging medication(s). See Appendix D
-
Current use of quinidine or systemic ketoconazole (topical ketoconazole is acceptable to use while on study).
-
History of dementia, Alzheimer's disease, multi-infarct dementia or clinically significant Cerebrovascular Accident (history of transient ischemic attack (TIA) is allowed).
-
Current use of donepezil, galantamine, rivastigmine, tacrine, memantine, methylphenidate, dextroamphetamine, or any other specific cognition enhancing drug(s). For patients who have used these medications, they must not have used them within 4 weeks prior to pre-screening. Patients who plan to start taking a cognition enhancing drug while on this study are also excluded.
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to donepezil. Hypersensitivity to donepezil.
-
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, recent myocardial infarction, cardiac arrhythmia.
-
Major medical conditions that affect cognition, traumatic brain injury, multiple sclerosis, acute severe fatigue, chronic fatigue syndrome or fibromyalgia.
-
Psychiatric illness/social situations that would limit compliance with study requirements including but not limited to a history of schizophrenia, psychosis or substance abuse.
-
Untreated current severe depression. Currently treated depression is permitted if treatment is stable.
-
Patients with a resting heart rate less than 55 beats per minute, seizure disorder or peptic ulcer disease (PUD).
-
History of congenital long QT syndrome or torsades de pointes.
-
Screening QTc of > 460 milliseconds will make the patient ineligible.
-
Pregnant women are excluded from this study. Following informed consent, women of child-bearing potential will be screened with a serum or urine pregnancy test within 10 days of enrollment. The effects of donepezil on the developing human fetus at the recommended therapeutic dose are unknown. For this reason and because donepezil is known to be teratogenic, women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her study physician immediately.
-
It is unknown whether donepezil is excreted in breast milk, for this reason women who are currently breast-feeding are not eligible for this study.
-
On another intervention study involving medication at the time of enrollment or during participation in this study. (Exception: Patients will remain eligible for this study if they are also enrolled on the Alliance for Clinical Trials in Oncology study (NCT02927249): Aspirin in Preventing Recurrence of Cancer in Patients with HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy. Studies that involve only blood draws or questionnaires are also permitted.)
-
Use of investigational drugs likely to affect cognition within 30 days prior to pre-screening visit.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Kaiser Permanente-Anaheim | Anaheim | California | United States | 92806 |
2 | Kaiser Permanente-Deer Valley Medical Center | Antioch | California | United States | 94531 |
3 | Kaiser Permanente-Baldwin Park | Baldwin Park | California | United States | 91706 |
4 | Kaiser Permanente-Bellflower | Bellflower | California | United States | 90706 |
5 | Kaiser Permanente-Fontana | Fontana | California | United States | 92335 |
6 | Kaiser Permanente-Fremont | Fremont | California | United States | 94538 |
7 | Fresno Cancer Center | Fresno | California | United States | 93720 |
8 | Kaiser Permanente-Fresno | Fresno | California | United States | 93720 |
9 | Kaiser Permanente - Harbor City | Harbor City | California | United States | 90710 |
10 | Kaiser Permanente-Irvine | Irvine | California | United States | 92618 |
11 | Kaiser Permanente Los Angeles Medical Center | Los Angeles | California | United States | 90027 |
12 | Kaiser Permanente West Los Angeles | Los Angeles | California | United States | 90034 |
13 | Kaiser Permanente-Modesto | Modesto | California | United States | 95356 |
14 | Kaiser Permanente-Oakland | Oakland | California | United States | 94611 |
15 | Kaiser Permanente-Ontario | Ontario | California | United States | 91761 |
16 | Kaiser Permanente - Panorama City | Panorama City | California | United States | 91402 |
17 | Kaiser Permanente-Rancho Cordova Cancer Center | Rancho Cordova | California | United States | 95670 |
18 | Kaiser Permanente-Richmond | Richmond | California | United States | 94801 |
19 | Kaiser Permanente-Riverside | Riverside | California | United States | 92505 |
20 | Kaiser Permanente-Roseville | Roseville | California | United States | 95661 |
21 | The Permanente Medical Group-Roseville Radiation Oncology | Roseville | California | United States | 95678 |
22 | Kaiser Permanente Downtown Commons | Sacramento | California | United States | 95814 |
23 | Kaiser Permanente-South Sacramento | Sacramento | California | United States | 95823 |
24 | South Sacramento Cancer Center | Sacramento | California | United States | 95823 |
25 | Kaiser Permanente - Sacramento | Sacramento | California | United States | 95825 |
26 | Kaiser Permanente-San Diego Zion | San Diego | California | United States | 92120 |
27 | Kaiser Permanente-San Francisco | San Francisco | California | United States | 94115 |
28 | Kaiser Permanente-Santa Teresa-San Jose | San Jose | California | United States | 95119 |
29 | Kaiser Permanente San Leandro | San Leandro | California | United States | 94577 |
30 | Kaiser Permanente-San Marcos | San Marcos | California | United States | 92078 |
31 | Kaiser Permanente-San Rafael | San Rafael | California | United States | 94903 |
32 | Kaiser San Rafael-Gallinas | San Rafael | California | United States | 94903 |
33 | Kaiser Permanente Medical Center - Santa Clara | Santa Clara | California | United States | 95051 |
34 | Kaiser Permanente-Santa Rosa | Santa Rosa | California | United States | 95403 |
35 | Kaiser Permanente-South San Francisco | South San Francisco | California | United States | 94080 |
36 | Kaiser Permanente-Stockton | Stockton | California | United States | 95210 |
37 | Kaiser Permanente Medical Center-Vacaville | Vacaville | California | United States | 95688 |
38 | Kaiser Permanente-Vallejo | Vallejo | California | United States | 94589 |
39 | Kaiser Permanente-Walnut Creek | Walnut Creek | California | United States | 94596 |
40 | Kaiser Permanente-Woodland Hills | Woodland Hills | California | United States | 91367 |
41 | Penrose-Saint Francis Healthcare | Colorado Springs | Colorado | United States | 80907 |
42 | Rocky Mountain Cancer Centers-Penrose | Colorado Springs | Colorado | United States | 80907 |
43 | Kaiser Permanente-Franklin | Denver | Colorado | United States | 80205 |
44 | Porter Adventist Hospital | Denver | Colorado | United States | 80210 |
45 | Kaiser Permanente-Rock Creek | Lafayette | Colorado | United States | 80026 |
46 | Littleton Adventist Hospital | Littleton | Colorado | United States | 80122 |
47 | Kaiser Permanente-Lone Tree | Lone Tree | Colorado | United States | 80124 |
48 | Longmont United Hospital | Longmont | Colorado | United States | 80501 |
49 | Parker Adventist Hospital | Parker | Colorado | United States | 80138 |
50 | Helen F Graham Cancer Center | Newark | Delaware | United States | 19713 |
51 | Medical Oncology Hematology Consultants PA | Newark | Delaware | United States | 19713 |
52 | Christiana Care Health System-Christiana Hospital | Newark | Delaware | United States | 19718 |
53 | Beebe Health Campus | Rehoboth Beach | Delaware | United States | 19971 |
54 | TidalHealth Nanticoke / Allen Cancer Center | Seaford | Delaware | United States | 19973 |
55 | Holy Cross Hospital | Fort Lauderdale | Florida | United States | 33308 |
56 | Pali Momi Medical Center | 'Aiea | Hawaii | United States | 96701 |
57 | Hawaii Cancer Care Inc - Waterfront Plaza | Honolulu | Hawaii | United States | 96813 |
58 | Queen's Cancer Cenrer - POB I | Honolulu | Hawaii | United States | 96813 |
59 | Queen's Medical Center | Honolulu | Hawaii | United States | 96813 |
60 | Straub Clinic and Hospital | Honolulu | Hawaii | United States | 96813 |
61 | University of Hawaii Cancer Center | Honolulu | Hawaii | United States | 96813 |
62 | Hawaii Cancer Care Inc-Liliha | Honolulu | Hawaii | United States | 96817 |
63 | Queen's Cancer Center - Kuakini | Honolulu | Hawaii | United States | 96817 |
64 | Kaiser Permanente Moanalua Medical Center | Honolulu | Hawaii | United States | 96819 |
65 | Kapiolani Medical Center for Women and Children | Honolulu | Hawaii | United States | 96826 |
66 | Saint Luke's Cancer Institute - Boise | Boise | Idaho | United States | 83712 |
67 | Saint Luke's Cancer Institute - Fruitland | Fruitland | Idaho | United States | 83619 |
68 | Saint Luke's Cancer Institute - Meridian | Meridian | Idaho | United States | 83642 |
69 | Saint Luke's Cancer Institute - Nampa | Nampa | Idaho | United States | 83686 |
70 | Saint Luke's Cancer Institute - Twin Falls | Twin Falls | Idaho | United States | 83301 |
71 | Illinois CancerCare-Bloomington | Bloomington | Illinois | United States | 61704 |
72 | Illinois CancerCare-Canton | Canton | Illinois | United States | 61520 |
73 | Centralia Oncology Clinic | Centralia | Illinois | United States | 62801 |
74 | Carle on Vermilion | Danville | Illinois | United States | 61832 |
75 | Cancer Care Specialists of Illinois - Decatur | Decatur | Illinois | United States | 62526 |
76 | Decatur Memorial Hospital | Decatur | Illinois | United States | 62526 |
77 | Carle Physician Group-Effingham | Effingham | Illinois | United States | 62401 |
78 | Crossroads Cancer Center | Effingham | Illinois | United States | 62401 |
79 | Illinois CancerCare-Galesburg | Galesburg | Illinois | United States | 61401 |
80 | Illinois CancerCare-Kewanee Clinic | Kewanee | Illinois | United States | 61443 |
81 | Carle Physician Group-Mattoon/Charleston | Mattoon | Illinois | United States | 61938 |
82 | Illinois CancerCare-Ottawa Clinic | Ottawa | Illinois | United States | 61350 |
83 | Illinois CancerCare-Pekin | Pekin | Illinois | United States | 61554 |
84 | Illinois CancerCare-Peoria | Peoria | Illinois | United States | 61615 |
85 | Illinois CancerCare-Peru | Peru | Illinois | United States | 61354 |
86 | Carle Cancer Center | Urbana | Illinois | United States | 61801 |
87 | The Carle Foundation Hospital | Urbana | Illinois | United States | 61801 |
88 | Physicians' Clinic of Iowa PC | Cedar Rapids | Iowa | United States | 52402 |
89 | Iowa Methodist Medical Center | Des Moines | Iowa | United States | 50309 |
90 | Medical Oncology and Hematology Associates-Des Moines | Des Moines | Iowa | United States | 50309 |
91 | Broadlawns Medical Center | Des Moines | Iowa | United States | 50314 |
92 | Mercy Medical Center - Des Moines | Des Moines | Iowa | United States | 50314 |
93 | Iowa Lutheran Hospital | Des Moines | Iowa | United States | 50316 |
94 | Methodist West Hospital | West Des Moines | Iowa | United States | 50266-7700 |
95 | Cancer Center of Kansas - Chanute | Chanute | Kansas | United States | 66720 |
96 | Cancer Center of Kansas - El Dorado | El Dorado | Kansas | United States | 67042 |
97 | Cancer Center of Kansas - Fort Scott | Fort Scott | Kansas | United States | 66701 |
98 | Cancer Center of Kansas-Independence | Independence | Kansas | United States | 67301 |
99 | Cancer Center of Kansas-Kingman | Kingman | Kansas | United States | 67068 |
100 | Cancer Center of Kansas-Manhattan | Manhattan | Kansas | United States | 66502 |
101 | Cancer Center of Kansas - McPherson | McPherson | Kansas | United States | 67460 |
102 | Cancer Center of Kansas - Newton | Newton | Kansas | United States | 67114 |
103 | Cancer Center of Kansas - Parsons | Parsons | Kansas | United States | 67357 |
104 | Cancer Center of Kansas - Salina | Salina | Kansas | United States | 67401 |
105 | Cancer Center of Kansas - Wellington | Wellington | Kansas | United States | 67152 |
106 | Associates In Womens Health | Wichita | Kansas | United States | 67208 |
107 | Cancer Center of Kansas-Wichita Medical Arts Tower | Wichita | Kansas | United States | 67208 |
108 | Ascension Via Christi Hospitals Wichita | Wichita | Kansas | United States | 67214 |
109 | Cancer Center of Kansas - Wichita | Wichita | Kansas | United States | 67214 |
110 | Cancer Center of Kansas - Winfield | Winfield | Kansas | United States | 67156 |
111 | Flaget Memorial Hospital | Bardstown | Kentucky | United States | 40004 |
112 | Saint Joseph Radiation Oncology Resource Center | Lexington | Kentucky | United States | 40504 |
113 | Saint Joseph Hospital East | Lexington | Kentucky | United States | 40509 |
114 | Saint Joseph London | London | Kentucky | United States | 40741 |
115 | Christus Saint Frances Cabrini Hospital | Alexandria | Louisiana | United States | 71301 |
116 | LSU Health Baton Rouge-North Clinic | Baton Rouge | Louisiana | United States | 70805 |
117 | Louisiana Hematology Oncology Associates LLC | Baton Rouge | Louisiana | United States | 70809 |
118 | Mary Bird Perkins Cancer Center | Baton Rouge | Louisiana | United States | 70809 |
119 | Our Lady of the Lake Physicians Group - Medical Oncology | Baton Rouge | Louisiana | United States | 70809 |
120 | Louisiana State University Health Science Center | New Orleans | Louisiana | United States | 70112 |
121 | University Medical Center New Orleans | New Orleans | Louisiana | United States | 70112 |
122 | Ochsner Medical Center Jefferson | New Orleans | Louisiana | United States | 70121 |
123 | CHRISTUS Highland Medical Center | Shreveport | Louisiana | United States | 71105 |
124 | Saint Joseph Mercy Hospital | Ann Arbor | Michigan | United States | 48106 |
125 | IHA Hematology Oncology Consultants-Brighton | Brighton | Michigan | United States | 48114 |
126 | Saint Joseph Mercy Brighton | Brighton | Michigan | United States | 48114 |
127 | IHA Hematology Oncology Consultants-Canton | Canton | Michigan | United States | 48188 |
128 | Saint Joseph Mercy Canton | Canton | Michigan | United States | 48188 |
129 | Caro Cancer Center | Caro | Michigan | United States | 48723 |
130 | IHA Hematology Oncology Consultants-Chelsea | Chelsea | Michigan | United States | 48118 |
131 | Saint Joseph Mercy Chelsea | Chelsea | Michigan | United States | 48118 |
132 | Hematology Oncology Consultants-Clarkston | Clarkston | Michigan | United States | 48346 |
133 | Newland Medical Associates-Clarkston | Clarkston | Michigan | United States | 48346 |
134 | Beaumont Hospital - Dearborn | Dearborn | Michigan | United States | 48124 |
135 | Green Bay Oncology - Escanaba | Escanaba | Michigan | United States | 49829 |
136 | Beaumont Hospital - Farmington Hills | Farmington Hills | Michigan | United States | 48336 |
137 | Genesee Cancer and Blood Disease Treatment Center | Flint | Michigan | United States | 48503 |
138 | Genesee Hematology Oncology PC | Flint | Michigan | United States | 48503 |
139 | Genesys Hurley Cancer Institute | Flint | Michigan | United States | 48503 |
140 | Hurley Medical Center | Flint | Michigan | United States | 48503 |
141 | Mercy Health Saint Mary's | Grand Rapids | Michigan | United States | 49503 |
142 | Spectrum Health at Butterworth Campus | Grand Rapids | Michigan | United States | 49503 |
143 | William Beaumont Hospital-Grosse Pointe | Grosse Pointe | Michigan | United States | 48230 |
144 | Saint Mary Mercy Hospital | Livonia | Michigan | United States | 48154 |
145 | Mercy Health Mercy Campus | Muskegon | Michigan | United States | 49444 |
146 | Newland Medical Associates-Pontiac | Pontiac | Michigan | United States | 48341 |
147 | Saint Joseph Mercy Oakland | Pontiac | Michigan | United States | 48341 |
148 | Spectrum Health Reed City Hospital | Reed City | Michigan | United States | 49677 |
149 | William Beaumont Hospital-Royal Oak | Royal Oak | Michigan | United States | 48073 |
150 | Ascension Saint Mary's Hospital | Saginaw | Michigan | United States | 48601 |
151 | Oncology Hematology Associates of Saginaw Valley PC | Saginaw | Michigan | United States | 48604 |
152 | Ascension Saint Joseph Hospital | Tawas City | Michigan | United States | 48764 |
153 | Munson Medical Center | Traverse City | Michigan | United States | 49684 |
154 | William Beaumont Hospital - Troy | Troy | Michigan | United States | 48085 |
155 | Saint Mary's Oncology/Hematology Associates of West Branch | West Branch | Michigan | United States | 48661 |
156 | Metro Health Hospital | Wyoming | Michigan | United States | 49519 |
157 | IHA Hematology Oncology Consultants-Ann Arbor | Ypsilanti | Michigan | United States | 48197 |
158 | Fairview Ridges Hospital | Burnsville | Minnesota | United States | 55337 |
159 | Mercy Hospital | Coon Rapids | Minnesota | United States | 55433 |
160 | Fairview Southdale Hospital | Edina | Minnesota | United States | 55435 |
161 | Unity Hospital | Fridley | Minnesota | United States | 55432 |
162 | Fairview Clinics and Surgery Center Maple Grove | Maple Grove | Minnesota | United States | 55369 |
163 | Minnesota Oncology Hematology PA-Maplewood | Maplewood | Minnesota | United States | 55109 |
164 | Saint John's Hospital - Healtheast | Maplewood | Minnesota | United States | 55109 |
165 | Abbott-Northwestern Hospital | Minneapolis | Minnesota | United States | 55407 |
166 | Hennepin County Medical Center | Minneapolis | Minnesota | United States | 55415 |
167 | Health Partners Inc | Minneapolis | Minnesota | United States | 55454 |
168 | New Ulm Medical Center | New Ulm | Minnesota | United States | 56073 |
169 | North Memorial Medical Health Center | Robbinsdale | Minnesota | United States | 55422 |
170 | Park Nicollet Clinic - Saint Louis Park | Saint Louis Park | Minnesota | United States | 55416 |
171 | Regions Hospital | Saint Paul | Minnesota | United States | 55101 |
172 | United Hospital | Saint Paul | Minnesota | United States | 55102 |
173 | Saint Francis Regional Medical Center | Shakopee | Minnesota | United States | 55379 |
174 | Lakeview Hospital | Stillwater | Minnesota | United States | 55082 |
175 | Ridgeview Medical Center | Waconia | Minnesota | United States | 55387 |
176 | Rice Memorial Hospital | Willmar | Minnesota | United States | 56201 |
177 | Minnesota Oncology Hematology PA-Woodbury | Woodbury | Minnesota | United States | 55125 |
178 | Fairview Lakes Medical Center | Wyoming | Minnesota | United States | 55092 |
179 | Baptist Memorial Hospital and Cancer Center-Golden Triangle | Columbus | Mississippi | United States | 39705 |
180 | Baptist Memorial Hospital and Cancer Center-Union County | New Albany | Mississippi | United States | 38652 |
181 | Baptist Memorial Hospital and Cancer Center-Oxford | Oxford | Mississippi | United States | 38655 |
182 | Baptist Memorial Hospital and Cancer Center-Desoto | Southhaven | Mississippi | United States | 38671 |
183 | Capital Region Southwest Campus | Jefferson City | Missouri | United States | 65109 |
184 | Missouri Baptist Medical Center | Saint Louis | Missouri | United States | 63131 |
185 | Mercy Hospital Springfield | Springfield | Missouri | United States | 65804 |
186 | CHI Health Good Samaritan | Kearney | Nebraska | United States | 68847 |
187 | Randolph Hospital | Asheboro | North Carolina | United States | 27203 |
188 | Mission Hospital | Asheville | North Carolina | United States | 28801 |
189 | AdventHealth Infusion Center Asheville | Asheville | North Carolina | United States | 28803 |
190 | Hope Women's Cancer Centers-Asheville | Asheville | North Carolina | United States | 28816 |
191 | Gaston Hematology and Oncology Associates-Belmont | Belmont | North Carolina | United States | 28012 |
192 | UNC Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | United States | 27599 |
193 | Wake Forest University at Clemmons | Clemmons | North Carolina | United States | 27012 |
194 | Southeastern Medical Oncology Center-Clinton | Clinton | North Carolina | United States | 28328 |
195 | CaroMont Regional Medical Center | Gastonia | North Carolina | United States | 28054 |
196 | Gaston Hematology and Oncology Associates | Gastonia | North Carolina | United States | 28054 |
197 | Southeastern Medical Oncology Center-Goldsboro | Goldsboro | North Carolina | United States | 27534 |
198 | Cone Health Cancer Center | Greensboro | North Carolina | United States | 27403 |
199 | Margaret R Pardee Memorial Hospital | Hendersonville | North Carolina | United States | 28791 |
200 | AdventHealth Hendersonville | Hendersonville | North Carolina | United States | 28792 |
201 | Southeastern Medical Oncology Center-Jacksonville | Jacksonville | North Carolina | United States | 28546 |
202 | Wake Forest University Health Sciences | Winston-Salem | North Carolina | United States | 27157 |
203 | Sanford Bismarck Medical Center | Bismarck | North Dakota | United States | 58501 |
204 | Sanford Broadway Medical Center | Fargo | North Dakota | United States | 58122 |
205 | Sanford Roger Maris Cancer Center | Fargo | North Dakota | United States | 58122 |
206 | Strecker Cancer Center-Belpre | Belpre | Ohio | United States | 45714 |
207 | Good Samaritan Hospital - Cincinnati | Cincinnati | Ohio | United States | 45220 |
208 | Bethesda North Hospital | Cincinnati | Ohio | United States | 45242 |
209 | TriHealth Cancer Institute-Westside | Cincinnati | Ohio | United States | 45247 |
210 | TriHealth Cancer Institute-Anderson | Cincinnati | Ohio | United States | 45255 |
211 | Columbus Oncology and Hematology Associates Inc | Columbus | Ohio | United States | 43214 |
212 | Riverside Methodist Hospital | Columbus | Ohio | United States | 43214 |
213 | Armes Family Cancer Center | Findlay | Ohio | United States | 45840 |
214 | Marietta Memorial Hospital | Marietta | Ohio | United States | 45750 |
215 | Licking Memorial Hospital | Newark | Ohio | United States | 43055 |
216 | Kaiser Permanente Northwest | Portland | Oregon | United States | 97227 |
217 | Geisinger Medical Center | Danville | Pennsylvania | United States | 17822 |
218 | Geisinger Medical Center-Cancer Center Hazleton | Hazleton | Pennsylvania | United States | 18201 |
219 | Geisinger Medical Oncology-Lewisburg | Lewisburg | Pennsylvania | United States | 17837 |
220 | Geisinger Cancer Services-Pottsville | Pottsville | Pennsylvania | United States | 17901 |
221 | Community Medical Center | Scranton | Pennsylvania | United States | 18510 |
222 | Geisinger Medical Oncology-Selinsgrove | Selinsgrove | Pennsylvania | United States | 17870 |
223 | Geisinger Wyoming Valley/Henry Cancer Center | Wilkes-Barre | Pennsylvania | United States | 18711 |
224 | AnMed Health Cancer Center | Anderson | South Carolina | United States | 29621 |
225 | Prisma Health Cancer Institute - Spartanburg | Boiling Springs | South Carolina | United States | 29316 |
226 | Prisma Health Cancer Institute - Easley | Easley | South Carolina | United States | 29640 |
227 | Gibbs Cancer Center-Gaffney | Gaffney | South Carolina | United States | 29341 |
228 | Tidelands Georgetown Memorial Hospital | Georgetown | South Carolina | United States | 29440 |
229 | Prisma Health Cancer Institute - Butternut | Greenville | South Carolina | United States | 29605 |
230 | Prisma Health Cancer Institute - Faris | Greenville | South Carolina | United States | 29605 |
231 | Prisma Health Cancer Institute - Eastside | Greenville | South Carolina | United States | 29615 |
232 | Self Regional Healthcare | Greenwood | South Carolina | United States | 29646 |
233 | Prisma Health Cancer Institute - Greer | Greer | South Carolina | United States | 29650 |
234 | Gibbs Cancer Center-Pelham | Greer | South Carolina | United States | 29651 |
235 | Prisma Health Cancer Institute - Seneca | Seneca | South Carolina | United States | 29672 |
236 | Spartanburg Medical Center | Spartanburg | South Carolina | United States | 29303 |
237 | MGC Hematology Oncology-Union | Union | South Carolina | United States | 29379 |
238 | Sanford Cancer Center Oncology Clinic | Sioux Falls | South Dakota | United States | 57104 |
239 | Sanford USD Medical Center - Sioux Falls | Sioux Falls | South Dakota | United States | 57117-5134 |
240 | Baptist Memorial Hospital and Cancer Center-Memphis | Memphis | Tennessee | United States | 38120 |
241 | Baptist Memorial Hospital for Women | Memphis | Tennessee | United States | 38120 |
242 | Family Cancer Center-Memphis | Memphis | Tennessee | United States | 38120 |
243 | Meharry Medical College | Nashville | Tennessee | United States | 37208 |
244 | Aurora Cancer Care-Southern Lakes VLCC | Burlington | Wisconsin | United States | 53105 |
245 | Marshfield Clinic-Chippewa Center | Chippewa Falls | Wisconsin | United States | 54729 |
246 | Marshfield Medical Center-EC Cancer Center | Eau Claire | Wisconsin | United States | 54701 |
247 | Aurora Health Center-Fond du Lac | Fond Du Lac | Wisconsin | United States | 54937 |
248 | Aurora Health Care Germantown Health Center | Germantown | Wisconsin | United States | 53022 |
249 | Aurora Cancer Care-Grafton | Grafton | Wisconsin | United States | 53024 |
250 | Saint Vincent Hospital Cancer Center Green Bay | Green Bay | Wisconsin | United States | 54301 |
251 | Saint Vincent Hospital Cancer Center at Saint Mary's | Green Bay | Wisconsin | United States | 54303 |
252 | Aurora BayCare Medical Center | Green Bay | Wisconsin | United States | 54311 |
253 | Aurora Cancer Care-Kenosha South | Kenosha | Wisconsin | United States | 53142 |
254 | Gundersen Lutheran Medical Center | La Crosse | Wisconsin | United States | 54601 |
255 | Marshfield Clinic - Ladysmith Center | Ladysmith | Wisconsin | United States | 54848 |
256 | Holy Family Memorial Hospital | Manitowoc | Wisconsin | United States | 54221 |
257 | Aurora Bay Area Medical Group-Marinette | Marinette | Wisconsin | United States | 54143 |
258 | Saint Vincent Hospital Cancer Center at Marinette | Marinette | Wisconsin | United States | 54143 |
259 | Marshfield Medical Center-Marshfield | Marshfield | Wisconsin | United States | 54449 |
260 | Aurora Cancer Care-Milwaukee | Milwaukee | Wisconsin | United States | 53209 |
261 | Aurora Saint Luke's Medical Center | Milwaukee | Wisconsin | United States | 53215 |
262 | Aurora Sinai Medical Center | Milwaukee | Wisconsin | United States | 53233 |
263 | Marshfield Clinic-Minocqua Center | Minocqua | Wisconsin | United States | 54548 |
264 | Cancer Center of Western Wisconsin | New Richmond | Wisconsin | United States | 54017 |
265 | Saint Vincent Hospital Cancer Center at Oconto Falls | Oconto Falls | Wisconsin | United States | 54154 |
266 | Vince Lombardi Cancer Clinic - Oshkosh | Oshkosh | Wisconsin | United States | 54904 |
267 | Aurora Cancer Care-Racine | Racine | Wisconsin | United States | 53406 |
268 | Marshfield Medical Center-Rice Lake | Rice Lake | Wisconsin | United States | 54868 |
269 | Vince Lombardi Cancer Clinic-Sheboygan | Sheboygan | Wisconsin | United States | 53081 |
270 | Marshfield Clinic Stevens Point Center | Stevens Point | Wisconsin | United States | 54482 |
271 | Saint Vincent Hospital Cancer Center at Sturgeon Bay | Sturgeon Bay | Wisconsin | United States | 54235-1495 |
272 | Aurora Medical Center in Summit | Summit | Wisconsin | United States | 53066 |
273 | Vince Lombardi Cancer Clinic-Two Rivers | Two Rivers | Wisconsin | United States | 54241 |
274 | Marshfield Clinic-Wausau Center | Wausau | Wisconsin | United States | 54401 |
275 | Aurora Cancer Care-Milwaukee West | Wauwatosa | Wisconsin | United States | 53226 |
276 | Aurora West Allis Medical Center | West Allis | Wisconsin | United States | 53227 |
277 | Marshfield Medical Center - Weston | Weston | Wisconsin | United States | 54476 |
278 | Marshfield Clinic - Wisconsin Rapids Center | Wisconsin Rapids | Wisconsin | United States | 54494 |
Sponsors and Collaborators
- Wake Forest University Health Sciences
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Stephen R Rapp, PhD, Wake Forest University Health Sciences
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRB00041707
- 3UG1CA189824-04S1
- WF-97116
- NCI-2016-01050
- IRB00041707
- NCI-2016-01050